Cargando…

On standardized relative survival

Cancer survival comparisons between cohorts are often assessed by estimates of relative or net survival. These measure the difference in mortality between those diagnosed with the disease and the general population. For such comparisons methods are needed to standardize cohort structure (including a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasieni, Peter, Brentnall, Adam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507182/
https://www.ncbi.nlm.nih.gov/pubmed/27554303
http://dx.doi.org/10.1111/biom.12578
_version_ 1783249698413346816
author Sasieni, Peter
Brentnall, Adam R.
author_facet Sasieni, Peter
Brentnall, Adam R.
author_sort Sasieni, Peter
collection PubMed
description Cancer survival comparisons between cohorts are often assessed by estimates of relative or net survival. These measure the difference in mortality between those diagnosed with the disease and the general population. For such comparisons methods are needed to standardize cohort structure (including age at diagnosis) and all‐cause mortality rates in the general population. Standardized non‐parametric relative survival measures are evaluated by determining how well they (i) ensure the correct rank ordering, (ii) allow for differences in covariate distributions, and (iii) possess robustness and maximal estimation precision. Two relative survival families that subsume the Ederer‐I, Ederer‐II, and Pohar‐Perme statistics are assessed. The aforementioned statistics do not meet our criteria, and are not invariant under a change of covariate distribution. Existing methods for standardization of these statistics are either not invariant to changes in the general population mortality or are not robust. Standardized statistics and estimators are developed to address the deficiencies. They use a reference distribution for covariates such as age, and a reference population mortality survival distribution that is recommended to approach zero with increasing age as fast as the cohort with the worst life expectancy. Estimators are compared using a breast‐cancer survival example and computer simulation. The proposals are invariant and robust, and out‐perform current methods to standardize the Ederer‐II and Pohar‐Perme estimators in simulations, particularly for extended follow‐up.
format Online
Article
Text
id pubmed-5507182
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55071822017-07-28 On standardized relative survival Sasieni, Peter Brentnall, Adam R. Biometrics Biometric Methodology Cancer survival comparisons between cohorts are often assessed by estimates of relative or net survival. These measure the difference in mortality between those diagnosed with the disease and the general population. For such comparisons methods are needed to standardize cohort structure (including age at diagnosis) and all‐cause mortality rates in the general population. Standardized non‐parametric relative survival measures are evaluated by determining how well they (i) ensure the correct rank ordering, (ii) allow for differences in covariate distributions, and (iii) possess robustness and maximal estimation precision. Two relative survival families that subsume the Ederer‐I, Ederer‐II, and Pohar‐Perme statistics are assessed. The aforementioned statistics do not meet our criteria, and are not invariant under a change of covariate distribution. Existing methods for standardization of these statistics are either not invariant to changes in the general population mortality or are not robust. Standardized statistics and estimators are developed to address the deficiencies. They use a reference distribution for covariates such as age, and a reference population mortality survival distribution that is recommended to approach zero with increasing age as fast as the cohort with the worst life expectancy. Estimators are compared using a breast‐cancer survival example and computer simulation. The proposals are invariant and robust, and out‐perform current methods to standardize the Ederer‐II and Pohar‐Perme estimators in simulations, particularly for extended follow‐up. John Wiley and Sons Inc. 2016-08-23 2017-06 /pmc/articles/PMC5507182/ /pubmed/27554303 http://dx.doi.org/10.1111/biom.12578 Text en © 2016 The Authors Biometrics published by Wiley Periodicals, Inc. on behalf of International Biometric Society This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Biometric Methodology
Sasieni, Peter
Brentnall, Adam R.
On standardized relative survival
title On standardized relative survival
title_full On standardized relative survival
title_fullStr On standardized relative survival
title_full_unstemmed On standardized relative survival
title_short On standardized relative survival
title_sort on standardized relative survival
topic Biometric Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507182/
https://www.ncbi.nlm.nih.gov/pubmed/27554303
http://dx.doi.org/10.1111/biom.12578
work_keys_str_mv AT sasienipeter onstandardizedrelativesurvival
AT brentnalladamr onstandardizedrelativesurvival